Kawasaki Disease-like Vasculitis Facilitates Atherosclerosis, and Statin Shows a Significant Antiatherosclerosis and Anti-Inflammatory Effect in a Kawasaki Disease Model Mouse.

Compared to the CAWS group, the CAWS + statin group had a decreasing trend after 6 weeks of CAWS administration and a significant decrease 10 weeks after CAWS administration (6 weeks: 20.6 ± 5.9% vs. 12.7 ± 6.1% [ p = 0.111]; 10 weeks: 33.0 ± 7.6% vs. 17.5 ± 3.9% [ p = 0.012]; Table 1 and Figure 2 a,b).

also in 47,180 other papers